SEC filing · 8-K

Silexion Therapeutics Corp: Material agreement

Silexion Therapeutics entered an agreement to reduce warrant exercise prices to raise approximately $0.84 million in gross proceeds.

Filed September 29, 2026

Mixed for the company

What happened

On September 28, 2026, Silexion entered into an inducement letter agreement with holders of 3,216,928 existing Series E warrants.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Silexion Therapeutics Corp

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.